Fresenius Medical Care (ETR:FME) Stock Passes Above 200-Day Moving Average – Should You Sell?

Fresenius Medical Care AG (ETR:FME)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of €40.39 ($42.52) and traded as high as €45.35 ($47.74). Fresenius Medical Care shares last traded at €44.68 ($47.03), with a volume of 247,059 shares trading hands.

Fresenius Medical Care Stock Down 1.7 %

The stock has a market cap of $12.98 billion, a PE ratio of 19.70, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a current ratio of 1.37, a quick ratio of 0.80 and a debt-to-equity ratio of 82.24. The business has a 50-day moving average price of €45.20 and a 200-day moving average price of €40.39.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.